¹û¶³Ó°Ôº

For World TB Day 2018, as part of our CCM ¹û¶³Ó°Ôº annual TB educational/CPD/advocacy contributions, Professor Sir Ali Zumla has led and coordinated three 'state of the art' reviews and five editorial comments in The Lancet journals, Nature Reviews Drugs Discovery and International Journal of Infectious Diseases.   

 has two substantive reviews co-authored by Professors Tim McHugh and Sir Zumla:
1) .
2) The second review details

A highlights the importance of the United National High Level Meeting on TB in September 2018 in New York. 

In ,Ìý²¹ details progress in Global TB care, prevention, and research in year 3 of the End TB era.  focuses on the need for more investments into TB research. .

In , a Comment by Sir Zumla and colleagues  highlight progress in the development of therapeutic strategies for drug-resistant tuberculosis.

In the International Journal of Infectious Diseases an  highlights the importance of taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB"

Downloads are also available via the links below:

Comment 1: Concrete action now: UN High-Level Meeting on Tuberculosis (Herbert et al)

Comment 2: Tuberculosis research and development: seeding the future (Lienhardt et al)

Comment 3: B cells or T cells in TB: a continuing conundrum

Comment 4: Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB"

Comment 5: Accelerating the development of therapeutic strategies for drug-resistant tuberculosis

Review 1: Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

Review 2: Tuberculosis: advances and challenges in development of new diagnostics and biomarkers

Review 3: The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era